Jesse D Sutton1,2, Ronald Carico3,4, Muriel Burk3,4, Makoto M Jones1,2,5, XiangMing Wei3,4, Melinda M Neuhauser3,4, Matthew Bidwell Goetz6,7, Kelly L Echevarria4, Emily S Spivak1,2,8, Francesca E Cunningham3,4. 1. Veterans Affairs Salt Lake City Healthcare System, Salt Lake City, Utah, USA. 2. VA Salt Lake City Informatics Decision-Enhancement and Analytic Sciences Center (IDEAS 2.0), Salt Lake City, Utah, USA. 3. Center for Medication Safety, Hines VA, Hines, Illinois, USA. 4. VA Pharmacy Benefits Management Services, Hines VA, Hines, Illinois, USA. 5. Department of Medicine, Division of Epidemiology, University of Utah School of Medicine, Salt Lake City, Utah, USA. 6. Veterans Affairs Greater Lost Angeles Healthcare System, Los Angeles, California, USA. 7. David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California, USA. 8. Department of Medicine, Division of Infectious Diseases, University of Utah School of Medicine, Salt Lake City, Utah, USA.
Abstract
BACKGROUND: Skin and soft tissue infections (SSTIs) are a key antimicrobial stewardship target because they are a common infection in hospitalized patients, and non-guideline-concordant antibiotic use is frequent. To inform antimicrobial stewardship interventions, we evaluated the proportion of veterans hospitalized with SSTIs who received guideline-concordant empiric antibiotics or an appropriate total duration of antibiotics. METHODS: A retrospective medication use evaluation was performed in 34 Veterans Affairs Medical Centers between 2016 and 2017. Hospitalized patients who received antibiotics for uncomplicated SSTI were included. Exclusion criteria were complicated SSTI, severe immunosuppression, and antibiotics for any non-SSTI indication. Data were collected by manual chart review. The primary outcome was the proportion of patients receiving both guideline-concordant empiric antibiotics and appropriate treatment duration, defined as 5-10 days of antibiotics. Data were analyzed and reported using descriptive statistics. RESULTS: Of the 3890 patients manually evaluated for inclusion, 1828 patients met inclusion criteria. There were 1299 nonpurulent (71%) and 529 purulent SSTIs (29%). Overall, 250 patients (14%) received guideline-concordant empiric therapy and an appropriate duration. The most common reason for non-guideline-concordance was receipt of antibiotics targeting methicillin-resistant Staphylococcus aureus (MRSA) in 906 patients (70%) with a nonpurulent SSTI. Additionally, 819 patients (45%) received broad-spectrum Gram-negative coverage, and 860 patients (48%) received an antibiotic duration >10 days. CONCLUSIONS: We identified 3 common opportunities to improve antibiotic use for patients hospitalized with uncomplicated SSTIs: use of anti-MRSA antibiotics in patients with nonpurulent SSTIs, use of broad-spectrum Gram-negative antibiotics, and prolonged durations of therapy. Published by Oxford University Press on behalf of Infectious Diseases Society of America 2020.
BACKGROUND: Skin and soft tissue infections (SSTIs) are a key antimicrobial stewardship target because they are a common infection in hospitalized patients, and non-guideline-concordant antibiotic use is frequent. To inform antimicrobial stewardship interventions, we evaluated the proportion of veterans hospitalized with SSTIs who received guideline-concordant empiric antibiotics or an appropriate total duration of antibiotics. METHODS: A retrospective medication use evaluation was performed in 34 Veterans Affairs Medical Centers between 2016 and 2017. Hospitalized patients who received antibiotics for uncomplicated SSTI were included. Exclusion criteria were complicated SSTI, severe immunosuppression, and antibiotics for any non-SSTI indication. Data were collected by manual chart review. The primary outcome was the proportion of patients receiving both guideline-concordant empiric antibiotics and appropriate treatment duration, defined as 5-10 days of antibiotics. Data were analyzed and reported using descriptive statistics. RESULTS: Of the 3890 patients manually evaluated for inclusion, 1828 patients met inclusion criteria. There were 1299 nonpurulent (71%) and 529 purulent SSTIs (29%). Overall, 250 patients (14%) received guideline-concordant empiric therapy and an appropriate duration. The most common reason for non-guideline-concordance was receipt of antibiotics targeting methicillin-resistant Staphylococcus aureus (MRSA) in 906 patients (70%) with a nonpurulent SSTI. Additionally, 819 patients (45%) received broad-spectrum Gram-negative coverage, and 860 patients (48%) received an antibiotic duration >10 days. CONCLUSIONS: We identified 3 common opportunities to improve antibiotic use for patients hospitalized with uncomplicated SSTIs: use of anti-MRSA antibiotics in patients with nonpurulent SSTIs, use of broad-spectrum Gram-negative antibiotics, and prolonged durations of therapy. Published by Oxford University Press on behalf of Infectious Diseases Society of America 2020.
Entities:
Keywords:
abscess; antibiotic stewardship; cellulitis; skin and soft tissue infections
Authors: Timothy C Jenkins; Bryan C Knepper; Allison L Sabel; Ellen E Sarcone; Jeremy A Long; Jason S Haukoos; Steven J Morgan; Walter L Biffl; Andrew W Steele; Connie S Price; Philip S Mehler; William J Burman Journal: Arch Intern Med Date: 2011-02-28
Authors: Shelley S Magill; Jonathan R Edwards; Zintars G Beldavs; Ghinwa Dumyati; Sarah J Janelle; Marion A Kainer; Ruth Lynfield; Joelle Nadle; Melinda M Neuhauser; Susan M Ray; Katherine Richards; Richard Rodriguez; Deborah L Thompson; Scott K Fridkin Journal: JAMA Date: 2014-10-08 Impact factor: 56.272
Authors: Timothy C Jenkins; Bryan C Knepper; S Jason Moore; Sean T O'Leary; Carla C Saveli; Sean W Pawlowski; Daniel M Perlman; Bruce D McCollister; William J Burman Journal: Infect Control Hosp Epidemiol Date: 2014-08-20 Impact factor: 3.254
Authors: Timothy C Jenkins; Teresa Hulett; Bryan C Knepper; Katherine C Shihadeh; Marc J Meyer; Gerard R Barber; John H Hammer; Heidi L Wald Journal: Clin Infect Dis Date: 2018-10-30 Impact factor: 9.079
Authors: Richard Brindle; O Martin Williams; Paul Davies; Tim Harris; Heather Jarman; Alastair D Hay; Peter Featherstone Journal: BMJ Open Date: 2017-03-17 Impact factor: 2.692
Authors: William O'Riordan; Alison McManus; Juri Teras; Ivan Poromanski; Maria Cruz-Saldariagga; Megan Quintas; Laura Lawrence; ShuJui Liang; Sue Cammarata Journal: Clin Infect Dis Date: 2018-08-16 Impact factor: 9.079
Authors: Daniel J Diekema; Michael A Pfaller; Dee Shortridge; Marcus Zervos; Ronald N Jones Journal: Open Forum Infect Dis Date: 2019-03-15 Impact factor: 3.835